74936-74-6

Basic information

• Product Name: Lercanidipine IMpurity A
• Synonyms: Lercanidipine IMpurity A
• CAS NO: 74936-74-6
• Molecular Formula: C19H22N2O6
• Molecular Weight: 374.39
• Mol File: 74936-74-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Lercanidipine IMpurity A(CAS DataBase Reference)
• NIST Chemistry Reference: Lercanidipine IMpurity A(74936-74-6)
• EPA Substance Registry System: Lercanidipine IMpurity A(74936-74-6)

Safety Data

• Hazardous Substances Data: 74936-74-6(Hazardous Substances Data)

Usage

Description

5-Butan-2-yloxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid is a complex organic compound with a chemical structure that includes a dihydropyridine ring and various functional groups. It is characterized by its potential pharmaceutical applications and is specifically known as an impurity in the synthesis of Lercanidipine, a dihydropyridine calcium channel blocker.

Uses

Used in Pharmaceutical Industry:
5-Butan-2-yloxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid is used as an impurity in the synthesis of [application type] for [application reason] Lercanidipine, a medication used to treat hypertension. Its presence in the synthesis process is crucial for ensuring the purity and efficacy of the final drug product.
Used in Research and Development:
In the field of pharmaceutical research and development, 5-Butan-2-yloxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid serves as a valuable compound for studying the properties and interactions of dihydropyridine derivatives. This can lead to the discovery of new therapeutic applications and the development of novel drugs with improved pharmacological profiles.
Used in Quality Control and Analysis:
5-Butan-2-yloxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid is also utilized in the quality control and analysis of dihydropyridine-based drugs. Its identification and quantification in pharmaceutical products help ensure that the drugs meet the required safety and efficacy standards.
Used in Drug Synthesis:
As an intermediate in the synthesis of dihydropyridine calcium channel blockers, 5-Butan-2-yloxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid plays a significant role in the development of new medications for the treatment of cardiovascular diseases, such as hypertension and angina pectoris.
Used in Drug Formulation:
In the formulation of dihydropyridine-based drugs, 5-Butan-2-yloxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid may be used to optimize the drug's stability, solubility, and bioavailability, ultimately enhancing its therapeutic effects and patient compliance.